Subacute Sclerosing Panencephalitis Ppt

Subacute sclerosing panencephalitis (SSPE) is a rare chronic, progressive encephalitis that affects primarily children and young adults, caused by a persistent infection of immune resistant measles virus (which can be a result of a mutation of the virus itself). No cure for SSPE exists, but the condition can be managed by medication if treatment is started at an early stage.

Viruses,  Viroids, and Prions
Lectures  prepared by Christine L. Case
Viruses,  Viroids, and Prions.ppt

Subacute-sclerosing  panencephalitis (SSPE)
Virology/NegStrandRNA2005B.ppt

Paramyxoviruses Measles, mumps,  parainfluenza virus, respiratory syncytial virus,  human metapneumovirus
AM_Paramyxo.ppt

Global  Health Update: Travel  & Tropical Medicine Seminar
Tropical Medicine Seminar.ppt

Latest 50 Published articles:

1. Subacute sclerosing panencephalitis (SSPE).
2. Subacute sclerosing panencephalitis (SSPE) the story of a vanishing disease.
3. Atypical presentation of adult-age onset subacute sclerosing panencephalitis.
4. Subacute Sclerosing Panencephalitis in a Toddler.
5. Are SCN1A gene mutations responsible for genetic susceptibility to subacute sclerosing panencephalitis?
6. Interferon production by cells infected with subacute sclerosing panencephalitis (SSPE) virus or measles virus.
7. The SI strain of measles virus derived from a patient with subacute sclerosing panencephalitis possesses typical genome alterations and unique amino acid changes that modulate receptor specificity and reduce membrane fusion activity.
8. Subacute sclerosing panencephalitis presenting as mania.
9. Cerebrospinal fluid apolipoprotein e levels in subacute sclerosing panencephalitis.
10. Imaging findings in bilateral macular chorioretinitis due to subacute sclerosing panencephalitis.
11. Drug-indiced aseptic meningitis: development of subacute sclerosing panencephalitis following repeated intraventricular infusion therapy with interferon alpha/beta.
12. Prognosis in subacute sclerosing panencephalitis.
13. Molecular characterization of measles virus strains causing subacute sclerosing panencephalitis in France in 1977 and 2007.
14. Subacute sclerosing panencephalitis presenting as mania.
15. Epidemiological findings and clinical and magnetic resonance presentations in subacute sclerosing panencephalitis.
16. An initial MRI picture of limbic encephalitis in subacute sclerosing panencephalitis.
17. Measles-vaccinated Israeli boy with subacute sclerosing panencephalitis.
18. Brainstem involvement in subacute sclerosing panencephalitis.
19. Brainstem involvement in subacute sclerosing panencephalitis.
20. Ocular findings in subacute sclerosing panencephalitis.
21. Correlation of quantitative diffusion tensor tractography with clinical grades of subacute sclerosing panencephalitis.
22. Subacute sclerosing panencephalitis: a case report.
23. Catatonia as the initial presenting feature of subacute sclerosing panencephalitis.
24. Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
25. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan (1977-2005)].
26. Epilepsia partialis continua in children with fulminant subacute sclerosing panencephalitis.
27. A woman with suspected subacute sclerosing panencephalitis (SSPE).
28. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
29. The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence.
30. A correlative study of FDG PET, MRI/CT, electroencephalography, and clinical features in subacute sclerosing panencephalitis.
31. Flupirtine may stop the progressive course of subacute sclerosing panencephalitis.
32. A 22-year-old Australian woman with atypical subacute sclerosing panencephalitis diagnosed at postmortem.
33. Subacute sclerosing panencephalitis: an update.
34. [Genetic susceptibility to infectious diseases: immunogenetical approaches to mycobacterial infections and subacute sclerosing panencephalitis].
35. 18F-FDG PET and MRS of the early stages of subacute sclerosing panencephalitis in a child with a normal initial MRI.
36. An unusual late presentation of subacute sclerosing panencephalitis with psychotic symptoms.
37. Midazolam or diazepam administration during electroencephalography helps to diagnose subacute sclerosing panencephalitis (SSPE).
38. Atypical presentations of subacute sclerosing panencephalitis in two neurologically handicapped cases.
39. PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis.
40. Tau proteins in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
41. Acute bilateral vision loss as the presenting feature of subacute sclerosing panencephalitis.
42. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
43. Cerebrospinal fluid nitric oxide levels in subacute sclerosing panencephalitis.
44. A short history of the long and productive search for the cause of subacute sclerosing panencephalitis.
45. Evaluation of lymphocyte subgroups in children with subacute sclerosing panencephalitis.
46. Adult fulminant subacute sclerosing panencephalitis: pathological and molecular studies--a case report.
47. [Serious complications of intraventricular interferon-alpha and ribavirin in the treatment of subacute sclerosing panencephalitis].
48. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis.
49. Single-point mutations of the M protein of a measles virus variant obtained from a patient with subacute sclerosing panencephalitis critically affect solubility and subcellular localization of the M protein and cell-free virus production.
50. Scoring clinical functions in subacute sclerosing panencephalitis.